STAAR Surgical to Present at BMO Capital Markets Focus on Heathcare Conference in...

STAAR Surgical to Present at BMO Capital Markets Focus on Heathcare Conference
in New York

MONROVIA, Calif., July 31 /PRNewswire-FirstCall/ -- STAAR Surgical Company
(Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally
invasive ophthalmic products, today announced today that Barry G. Caldwell,
President and Chief Executive Officer will present at the 2008 BMO Capital
Markets Focus on Healthcare Conference at the Millennium Broadway Hotel on
Tuesday, August 5th at 10:45am Eastern Time.
Interested parties can access a live audio web cast of the presentation at
http://www.staar.com. A replay of the presentation will be available at the
same location.
About STAAR Surgical
STAAR Surgical is a leader in the development, manufacture and marketing
of minimally invasive ophthalmic products employing proprietary technologies.
STAAR's products are used by ophthalmic surgeons and include the Visian ICL, a
tiny, flexible lens implanted to correct refractive errors, as well as
innovative products designed to improve patient outcomes for cataracts and
glaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by the
FDA for use in treating myopia, has received CE Marking and is sold in more
than 40 countries. Collamer(R) is the brand name for STAAR's proprietary
collagen copolymer lens material. More information is available at
http://www.staar.com.
CONTACT: Investors Media
EVC Group EVC Group
Douglas Sherk, 415-896-6820 Steve DiMattia 646-201-5445
Dahlia Bailey, 415-896-5862

SOURCE STAAR Surgical Company

investors, Douglas Sherk, +1-415-896-6820, or Dahlia Bailey, +1-415-896-5862,
or media, Steve DiMattia, +1-646-201-5445, all of EVC Group for STAAR Surgical
Company